Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...

In this video, Aruna Padmanabhan, MD, discusses the evaluation of PI3K inhibitor combinations as first-line treatment for patients with metastatic breast cancer.

The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

Engulfing Bearish 15 69 Jan 29, 2025 12:15 ...

follow in the chart below. A complete list of Pfizer-sponsored accepted abstracts is available here. *TALZENNA in combination with XTANDI was approved by the U.S. Food and Drug Administration (FDA ...

New drugs like Carvykti ... At present, Spravato is approved in combination with an oral antidepressant to treat adults with TRD and depressive symptoms in adults with major depressive disorder ...

Buy DRUG near 34.19 target 54.82 stop loss @ 34.09 Details The technical summary data tells us to buy DRUG near 34.19 with an upside target of 54.82. This data also tells us to set a stop loss @ 34.09 ...

Credit: Sorbetto via Getty Images. Johnson & Johnson’s (J&J) combination therapy of Lazcluze (lazertinib) and Rybrevant (amivantamab-vmjw) has been granted marketing authorisation by the European ...

Researchers found that a combination therapy of two drugs disrupts this pathway, helping to suppress the creation of cancer cells and tumor growth. This combo of medications includes a statin ...